Bardy Diagnostics logo

Bardy Diagnostics

bardydx.com

Bardy Diagnostics develops ambulatory ECG monitoring solutions, including the Carnation Ambulatory Monitor (CAM) Patch, which is a lightweight, extended-wear cardiac patch monitor designed to optimize P-wave signal capture for more accurate arrhythmia detection. Its products are used by healthcare professionals to obtain clear and actionable cardiac event data for patient diagnosis and management. The organization aims to improve the quality and accuracy of ambulatory cardiac monitoring to support better patient outcomes.

Facts

HQ
Seattle
Sectors
Medical devices, Healthcare technology, Cardiology diagnostic devices, Patient monitoring
Founded
2013
Type
Corporation Seattle business license
Registered name
Bardy Diagnostics Inc Seattle business license
Stage
former-startup
Members see funding amounts.
.
Founders
Gust H. Bardy, M.D.

Is this your organization? Claim it

Hillrom to Buy Bardy Diagnostics for $375 Million, Adding CAM Wearable ECG Patch and P‑Wave Signal Technology

Hillrom will acquire Bardy Diagnostics for $375 million in cash plus potential milestone payments, adding BardyDx’s CAM wearable cardiac-monitoring patch and its P-wave–focused signal-processing tech to Hillrom’s cardiology portfolio; BardyDx reports $30 million annualized revenue, over $20 million net operating losses, and about 230 employees. The deal is expected to close in Hillrom’s fiscal Q2 2021, subject to customary closing conditions.

See all 10 stories, episodes and videos about Bardy Diagnostics.

People

Online